Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone for Co-occurring Opioid and ATS Dependence
NCT02541513Phase 3Unknown
- Sponsor
- Universiti Sains Malaysia
- Start
- May 2013
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of paliperidone in opioid use disorder (OUD) and amphetamine dependence, sponsored by Universiti Sains Malaysia. Primary endpoint: Reduction in illicit ATS use at 18 weeks. Status: unknown.
02
Drugs
paliperidone
03
Conditions
opioid use disorder (OUD)amphetamine dependence
Beyond the preview
Go deeper on NCT02541513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02541513.